These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24201825)

  • 1. Structural glycobiology of heparin dynamics on the exosite 2 of coagulation cascade proteases: Implications for glycosaminoglycans antithrombotic activity.
    Pol-Fachin L; Verli H
    Glycobiology; 2014 Jan; 24(1):97-105. PubMed ID: 24201825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency.
    Kovács B; Bereczky Z; Oláh Z; Gindele R; Kerényi A; Selmeczi A; Boda Z; Muszbek L
    Am J Clin Pathol; 2013 Nov; 140(5):675-9. PubMed ID: 24124146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common protein C inhibitor exosite partially controls the heparin induced activation and inhibition of serine proteases.
    Siddiqui U; Khan AB; Ahmad T; Rehman AA; Jairajpuri MA
    Int J Biol Macromol; 2024 May; 266(Pt 2):131065. PubMed ID: 38521329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS; Roy KK; Saxena AK
    J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glycosylation on heparin binding and antithrombin activation by heparin.
    Pol-Fachin L; Franco Becker C; Almeida Guimarães J; Verli H
    Proteins; 2011 Sep; 79(9):2735-45. PubMed ID: 21769943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin.
    Izaguirre G; Swanson R; Raja SM; Rezaie AR; Olson ST
    J Biol Chem; 2007 Nov; 282(46):33609-33622. PubMed ID: 17875649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated Factor X-Based versus Thrombin-Based Antithrombin Testing in Thrombophilia Workup in the DOAC Era.
    Rühl H; Reda S; Müller J; Oldenburg J; Pötzsch B
    Thromb Haemost; 2018 Feb; 118(2):381-387. PubMed ID: 29378360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of SanOrg123781A, a synthetic hexadecasaccharide, on clot-bound thrombin and factor Xa in vitro and in vivo.
    Hérault JP; Cappelle M; Bernat A; Millet L; Bono F; Schaeffer P; Herbert JM
    J Thromb Haemost; 2003 Sep; 1(9):1959-65. PubMed ID: 12941037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic properties of the native free antithrombin from molecular dynamics simulations: computational evidence for solvent- exposed Arg393 side chain.
    Tóth L; Fekete A; Balogh G; Bereczky Z; Komáromi I
    J Biomol Struct Dyn; 2015 Sep; 33(9):2023-36. PubMed ID: 25483839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Na+ binding channel of human coagulation proteases: novel insights on the structure and allosteric modulation revealed by molecular surface analysis.
    Silva FP; Antunes OA; de Alencastro RB; De Simone SG
    Biophys Chem; 2006 Feb; 119(3):282-94. PubMed ID: 16288954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of structural information in the discovery of direct thrombin and factor Xa inhibitors.
    Nar H
    Trends Pharmacol Sci; 2012 May; 33(5):279-88. PubMed ID: 22503439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring complex formation in the blood-coagulation cascade using aptamer-coated SAW sensors.
    Gronewold TM; Glass S; Quandt E; Famulok M
    Biosens Bioelectron; 2005 Apr; 20(10):2044-52. PubMed ID: 15741074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ixolaris: a factor Xa heparin-binding exosite inhibitor.
    Monteiro RQ; Rezaie AR; Ribeiro JM; Francischetti IM
    Biochem J; 2005 May; 387(Pt 3):871-7. PubMed ID: 15617517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
    Nakamura R; Umemura K; Hashimmoto H; Urano T
    Thromb Haemost; 2006 Apr; 95(4):637-42. PubMed ID: 16601834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sulfation on antithrombin-thrombin/factor Xa interactions in semisynthetic low molecular weight heparins.
    Sissi C; Naggi A; Torri G; Palumbo M
    Semin Thromb Hemost; 2001 Oct; 27(5):483-7. PubMed ID: 11668417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfated low molecular weight lignins, allosteric inhibitors of coagulation proteinases via the heparin binding site, significantly alter the active site of thrombin and factor xa compared to heparin.
    Henry BL; Desai UR
    Thromb Res; 2014 Nov; 134(5):1123-9. PubMed ID: 25242245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.